Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Amantadine for Freezing of Gait in Parkinson's Disease
NCT01313819Phase 4Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Apr 2011
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of amantadine hydrochloride intravenous solution in Parkinson's disease (PD) and Freezing of gait (FOG) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Freezing of Gait Questionnaire Score Change at 2 days. Status: unknown.
02
Drugs
amantadine hydrochloride intravenous solution
03
Conditions
Parkinson's disease (PD)Freezing of gait (FOG)
Beyond the preview
Go deeper on NCT01313819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01313819.